Ebanicline

N/A

Report date: 2022/05/16 17:57:06
NME

Base Information

Drug NameEbanicline
Drug Alias Name替巴克兰TebaniclineABT-594ABT-165594ABT-16659447
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma agonists
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsPainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbvie Inc
Active IndicationsN/A
Inactive IndicationsPainNeuralgia

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG